2018 (4th) International Symposium on Next-GEneration CAR & TCR-T Cells
Chimeric antiGEn receptors are engineered receptors that combine a new specificity with an immune cell to tarGEt cancer cells. Typically, these receptors graft the specificity of a monoclonal antibody onto a T cell. CAR-T cells are a new type of treatment that uses living cells that have been transformed.
2018 (3rd) International Innovative Forum on Biomedical Materials and Tissue Repair & ReGEneration
In response to China's 13th five-year plan for new medical materials, this forum on tissue repair & reGEneration focuses on key technologies like 3D bioprinting, surface biofunctionalization and modification of materials, aiming to achieve innovation, cooperation and win-win across the borders of all countries.
2018 Symposium on Cancer Evolution and HeteroGEneity
HeteroGEneity is a major challenGE in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. With the developments of new technologies, there emerGE successive achievements with great significance on clinical therapeutics. This symposium will focus on cancer heteroGEneity, promoting the clinical translation of research.
2018 (2nd) Frontier Symposium on Brain Science and Brain-Inspired IntelliGEnce
Leaders of China Brain Project, domestic well-known experts in the fields of neuromorphic engineering, brain science, artificial intelliGEnce, and neural medicine will be invited, to communicate with delegates about research on human brain, development trend of brain-inspired intelliGEnce.
2018 Forum on Next GEneration High Sensitivity Testing Technology and Application
Including topics like liquid biopsy, microfluidics and exosomes, this forum will focus on basic research, clinical application, technology R&D as well as industrialization. Bioon's missions are to pave the way for discovery of new biomarkers and to facilitate developments of in vitro diagnostics ( IVD ) & early cancer detection!
2018 International Conference on GEne Editing and GEne Therapy
Promoting the reasonable application and clinical translation of GEne editing technology iss of great importance. In addition, there are many researchers and clinicians caring about progress of GEne therapy. Therefore, Bioon is going to hold the 2018 International Conference on GEne Editing and GEne Therapy, so as to improve exchanGE and cooperation among all sides.
2017”肿瘤免疫+”研讨会：Better ToGEther
近年来，随着生物技术的发展，肿瘤免疫疗法成为继肿瘤手术， 放疗，化疗， 靶向治疗后的最有希望能成功治愈癌症的手段，亮点迭出。然而单纯采用肿瘤免疫治疗还存在不足，因此，不同肿瘤免疫疗法的联合应用将是癌症治疗的未来趋势。